NexgenRx Proclaims 2021 12 months Finish Outcomes with Important Income Progress and $3.5m EBITDA
TORONTO, ON / ACCESSWIRE / March 25, 2022 / NEXGENRX INC. (“NexgenRx” or the “Firm”) is happy to announce its ...
TORONTO, ON / ACCESSWIRE / March 25, 2022 / NEXGENRX INC. (“NexgenRx” or the “Firm”) is happy to announce its ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.